Global Cabazitaxel Market Growth 2022-2028
- LP 4696388
- 75 Pages
- January 2022
- Pharmaceuticals
The United States Cabazitaxel market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cabazitaxel market, reaching US$ million by the year 2028. As for the Europe Cabazitaxel landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cabazitaxel players cover Sanofi, Tapi Teva, Fuan Pharmaceutical Group, and Fujian Yewpark Biological, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cabazitaxel market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Purity above 99%
Other Purity
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Age Below 65
Age Above 65
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cabazitaxel Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cabazitaxel by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cabazitaxel by Country/Region, 2017, 2022 & 2028
2.2 Cabazitaxel Segment by Type
2.2.1 Purity above 99%
2.2.2 Other Purity
2.3 Cabazitaxel Sales by Type
2.3.1 Global Cabazitaxel Sales Market Share by Type (2017-2022)
2.3.2 Global Cabazitaxel Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cabazitaxel Sale Price by Type (2017-2022)
2.4 Cabazitaxel Segment by Application
2.4.1 Age Below 65
2.4.2 Age Above 65
2.5 Cabazitaxel Sales by Application
2.5.1 Global Cabazitaxel Sale Market Share by Application (2017-2022)
2.5.2 Global Cabazitaxel Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cabazitaxel Sale Price by Application (2017-2022)
3 Global Cabazitaxel by Company
3.1 Global Cabazitaxel Breakdown Data by Company
3.1.1 Global Cabazitaxel Annual Sales by Company (2020-2022)
3.1.2 Global Cabazitaxel Sales Market Share by Company (2020-2022)
3.2 Global Cabazitaxel Annual Revenue by Company (2020-2022)
3.2.1 Global Cabazitaxel Revenue by Company (2020-2022)
3.2.2 Global Cabazitaxel Revenue Market Share by Company (2020-2022)
3.3 Global Cabazitaxel Sale Price by Company
3.4 Key Manufacturers Cabazitaxel Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cabazitaxel Product Location Distribution
3.4.2 Players Cabazitaxel Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cabazitaxel by Geographic Region
4.1 World Historic Cabazitaxel Market Size by Geographic Region (2017-2022)
4.1.1 Global Cabazitaxel Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cabazitaxel Annual Revenue by Geographic Region
4.2 World Historic Cabazitaxel Market Size by Country/Region (2017-2022)
4.2.1 Global Cabazitaxel Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cabazitaxel Annual Revenue by Country/Region
4.3 Americas Cabazitaxel Sales Growth
4.4 APAC Cabazitaxel Sales Growth
4.5 Europe Cabazitaxel Sales Growth
4.6 Middle East & Africa Cabazitaxel Sales Growth
5 Americas
5.1 Americas Cabazitaxel Sales by Country
5.1.1 Americas Cabazitaxel Sales by Country (2017-2022)
5.1.2 Americas Cabazitaxel Revenue by Country (2017-2022)
5.2 Americas Cabazitaxel Sales by Type
5.3 Americas Cabazitaxel Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cabazitaxel Sales by Region
6.1.1 APAC Cabazitaxel Sales by Region (2017-2022)
6.1.2 APAC Cabazitaxel Revenue by Region (2017-2022)
6.2 APAC Cabazitaxel Sales by Type
6.3 APAC Cabazitaxel Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cabazitaxel by Country
7.1.1 Europe Cabazitaxel Sales by Country (2017-2022)
7.1.2 Europe Cabazitaxel Revenue by Country (2017-2022)
7.2 Europe Cabazitaxel Sales by Type
7.3 Europe Cabazitaxel Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cabazitaxel by Country
8.1.1 Middle East & Africa Cabazitaxel Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cabazitaxel Revenue by Country (2017-2022)
8.2 Middle East & Africa Cabazitaxel Sales by Type
8.3 Middle East & Africa Cabazitaxel Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cabazitaxel
10.3 Manufacturing Process Analysis of Cabazitaxel
10.4 Industry Chain Structure of Cabazitaxel
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cabazitaxel Distributors
11.3 Cabazitaxel Customer
12 World Forecast Review for Cabazitaxel by Geographic Region
12.1 Global Cabazitaxel Market Size Forecast by Region
12.1.1 Global Cabazitaxel Forecast by Region (2023-2028)
12.1.2 Global Cabazitaxel Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cabazitaxel Forecast by Type
12.7 Global Cabazitaxel Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Cabazitaxel Product Offered
13.1.3 Sanofi Cabazitaxel Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Tapi Teva
13.2.1 Tapi Teva Company Information
13.2.2 Tapi Teva Cabazitaxel Product Offered
13.2.3 Tapi Teva Cabazitaxel Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Tapi Teva Main Business Overview
13.2.5 Tapi Teva Latest Developments
13.3 Fuan Pharmaceutical Group
13.3.1 Fuan Pharmaceutical Group Company Information
13.3.2 Fuan Pharmaceutical Group Cabazitaxel Product Offered
13.3.3 Fuan Pharmaceutical Group Cabazitaxel Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Fuan Pharmaceutical Group Main Business Overview
13.3.5 Fuan Pharmaceutical Group Latest Developments
13.4 Fujian Yewpark Biological
13.4.1 Fujian Yewpark Biological Company Information
13.4.2 Fujian Yewpark Biological Cabazitaxel Product Offered
13.4.3 Fujian Yewpark Biological Cabazitaxel Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Fujian Yewpark Biological Main Business Overview
13.4.5 Fujian Yewpark Biological Latest Developments
14 Research Findings and Conclusion
Table 1. Cabazitaxel Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cabazitaxel Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity above 99%
Table 4. Major Players of Other Purity
Table 5. Global Cabazitaxel Sales by Type (2017-2022) & (Kg)
Table 6. Global Cabazitaxel Sales Market Share by Type (2017-2022)
Table 7. Global Cabazitaxel Revenue by Type (2017-2022) & ($ million)
Table 8. Global Cabazitaxel Revenue Market Share by Type (2017-2022)
Table 9. Global Cabazitaxel Sale Price by Type (2017-2022) & (USD/g)
Table 10. Global Cabazitaxel Sales by Application (2017-2022) & (Kg)
Table 11. Global Cabazitaxel Sales Market Share by Application (2017-2022)
Table 12. Global Cabazitaxel Revenue by Application (2017-2022)
Table 13. Global Cabazitaxel Revenue Market Share by Application (2017-2022)
Table 14. Global Cabazitaxel Sale Price by Application (2017-2022) & (USD/g)
Table 15. Global Cabazitaxel Sales by Company (2020-2022) & (Kg)
Table 16. Global Cabazitaxel Sales Market Share by Company (2020-2022)
Table 17. Global Cabazitaxel Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Cabazitaxel Revenue Market Share by Company (2020-2022)
Table 19. Global Cabazitaxel Sale Price by Company (2020-2022) & (USD/g)
Table 20. Key Manufacturers Cabazitaxel Producing Area Distribution and Sales Area
Table 21. Players Cabazitaxel Products Offered
Table 22. Cabazitaxel Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cabazitaxel Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Cabazitaxel Sales Market Share Geographic Region (2017-2022)
Table 27. Global Cabazitaxel Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Cabazitaxel Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Cabazitaxel Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Cabazitaxel Sales Market Share by Country/Region (2017-2022)
Table 31. Global Cabazitaxel Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Cabazitaxel Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Cabazitaxel Sales by Country (2017-2022) & (Kg)
Table 34. Americas Cabazitaxel Sales Market Share by Country (2017-2022)
Table 35. Americas Cabazitaxel Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Cabazitaxel Revenue Market Share by Country (2017-2022)
Table 37. Americas Cabazitaxel Sales by Type (2017-2022) & (Kg)
Table 38. Americas Cabazitaxel Sales Market Share by Type (2017-2022)
Table 39. Americas Cabazitaxel Sales by Application (2017-2022) & (Kg)
Table 40. Americas Cabazitaxel Sales Market Share by Application (2017-2022)
Table 41. APAC Cabazitaxel Sales by Region (2017-2022) & (Kg)
Table 42. APAC Cabazitaxel Sales Market Share by Region (2017-2022)
Table 43. APAC Cabazitaxel Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Cabazitaxel Revenue Market Share by Region (2017-2022)
Table 45. APAC Cabazitaxel Sales by Type (2017-2022) & (Kg)
Table 46. APAC Cabazitaxel Sales Market Share by Type (2017-2022)
Table 47. APAC Cabazitaxel Sales by Application (2017-2022) & (Kg)
Table 48. APAC Cabazitaxel Sales Market Share by Application (2017-2022)
Table 49. Europe Cabazitaxel Sales by Country (2017-2022) & (Kg)
Table 50. Europe Cabazitaxel Sales Market Share by Country (2017-2022)
Table 51. Europe Cabazitaxel Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Cabazitaxel Revenue Market Share by Country (2017-2022)
Table 53. Europe Cabazitaxel Sales by Type (2017-2022) & (Kg)
Table 54. Europe Cabazitaxel Sales Market Share by Type (2017-2022)
Table 55. Europe Cabazitaxel Sales by Application (2017-2022) & (Kg)
Table 56. Europe Cabazitaxel Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Cabazitaxel Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Cabazitaxel Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Cabazitaxel Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Cabazitaxel Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Cabazitaxel Sales by Type (2017-2022) & (Kg)
Table 62. Middle East & Africa Cabazitaxel Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Cabazitaxel Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Cabazitaxel Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Cabazitaxel
Table 66. Key Market Challenges & Risks of Cabazitaxel
Table 67. Key Industry Trends of Cabazitaxel
Table 68. Cabazitaxel Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Cabazitaxel Distributors List
Table 71. Cabazitaxel Customer List
Table 72. Global Cabazitaxel Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Cabazitaxel Sales Market Forecast by Region
Table 74. Global Cabazitaxel Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Cabazitaxel Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Cabazitaxel Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Cabazitaxel Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Cabazitaxel Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Cabazitaxel Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Cabazitaxel Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Cabazitaxel Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Cabazitaxel Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Cabazitaxel Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Cabazitaxel Sales Forecast by Type (2023-2028) & (Kg)
Table 85. Global Cabazitaxel Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Cabazitaxel Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Cabazitaxel Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Cabazitaxel Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Cabazitaxel Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Cabazitaxel Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Cabazitaxel Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Cabazitaxel Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Cabazitaxel Product Offered
Table 94. Sanofi Cabazitaxel Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Tapi Teva Basic Information, Cabazitaxel Manufacturing Base, Sales Area and Its Competitors
Table 98. Tapi Teva Cabazitaxel Product Offered
Table 99. Tapi Teva Cabazitaxel Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 100. Tapi Teva Main Business
Table 101. Tapi Teva Latest Developments
Table 102. Fuan Pharmaceutical Group Basic Information, Cabazitaxel Manufacturing Base, Sales Area and Its Competitors
Table 103. Fuan Pharmaceutical Group Cabazitaxel Product Offered
Table 104. Fuan Pharmaceutical Group Cabazitaxel Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 105. Fuan Pharmaceutical Group Main Business
Table 106. Fuan Pharmaceutical Group Latest Developments
Table 107. Fujian Yewpark Biological Basic Information, Cabazitaxel Manufacturing Base, Sales Area and Its Competitors
Table 108. Fujian Yewpark Biological Cabazitaxel Product Offered
Table 109. Fujian Yewpark Biological Cabazitaxel Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
Table 110. Fujian Yewpark Biological Main Business
Table 111. Fujian Yewpark Biological Latest Developments
List of Figures
Figure 1. Picture of Cabazitaxel
Figure 2. Cabazitaxel Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cabazitaxel Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Cabazitaxel Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cabazitaxel Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity above 99%
Figure 10. Product Picture of Other Purity
Figure 11. Global Cabazitaxel Sales Market Share by Type in 2021
Figure 12. Global Cabazitaxel Revenue Market Share by Type (2017-2022)
Figure 13. Cabazitaxel Consumed in Age Below 65
Figure 14. Global Cabazitaxel Market: Age Below 65 (2017-2022) & (Kg)
Figure 15. Cabazitaxel Consumed in Age Above 65
Figure 16. Global Cabazitaxel Market: Age Above 65 (2017-2022) & (Kg)
Figure 17. Global Cabazitaxel Sales Market Share by Application (2017-2022)
Figure 18. Global Cabazitaxel Revenue Market Share by Application in 2021
Figure 19. Cabazitaxel Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Cabazitaxel Revenue Market Share by Company in 2021
Figure 21. Global Cabazitaxel Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Cabazitaxel Revenue Market Share by Geographic Region in 2021
Figure 23. Global Cabazitaxel Sales Market Share by Region (2017-2022)
Figure 24. Global Cabazitaxel Revenue Market Share by Country/Region in 2021
Figure 25. Americas Cabazitaxel Sales 2017-2022 (Kg)
Figure 26. Americas Cabazitaxel Revenue 2017-2022 ($ Millions)
Figure 27. APAC Cabazitaxel Sales 2017-2022 (Kg)
Figure 28. APAC Cabazitaxel Revenue 2017-2022 ($ Millions)
Figure 29. Europe Cabazitaxel Sales 2017-2022 (Kg)
Figure 30. Europe Cabazitaxel Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Cabazitaxel Sales 2017-2022 (Kg)
Figure 32. Middle East & Africa Cabazitaxel Revenue 2017-2022 ($ Millions)
Figure 33. Americas Cabazitaxel Sales Market Share by Country in 2021
Figure 34. Americas Cabazitaxel Revenue Market Share by Country in 2021
Figure 35. United States Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Cabazitaxel Sales Market Share by Region in 2021
Figure 40. APAC Cabazitaxel Revenue Market Share by Regions in 2021
Figure 41. China Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Cabazitaxel Sales Market Share by Country in 2021
Figure 48. Europe Cabazitaxel Revenue Market Share by Country in 2021
Figure 49. Germany Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Cabazitaxel Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Cabazitaxel Revenue Market Share by Country in 2021
Figure 56. Egypt Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Cabazitaxel Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Cabazitaxel in 2021
Figure 62. Manufacturing Process Analysis of Cabazitaxel
Figure 63. Industry Chain Structure of Cabazitaxel
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
